A Study of Baricitinib (LY3009104) in Healthy Chinese Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The main purpose of this study is to investigate the safety and tolerability of the study drug known as baricitinib in healthy Chinese participants. The study will measure how the body absorbs, breaks down and gets rid of baricitinib. The study will last about 20 days, not including screening. This study is for research purposes only, and is not intended to treat any medical condition.
Epistemonikos ID: 98749501c1246af2c5393e65295b922425eee55e
First added on: May 13, 2024